← All Sponsors
SPONSOR

West China Hospital

Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1, Phase 1

West China Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Biliary Tract Cancer, Hepatocellular Carcinoma, Hepatectomy, Laparoscopic Hepatectomy.

The trial portfolio spans Phase 1, Phase 2, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — West China Hospital

How many clinical trials has West China Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by West China Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Biliary Tract Cancer, Hepatocellular Carcinoma, Hepatectomy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does West China Hospital research focus on?
West China Hospital clinical trials span Biliary Tract Cancer, Hepatocellular Carcinoma, Hepatectomy, Laparoscopic Hepatectomy, Colon Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a West China Hospital clinical trial?
To participate in a West China Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all West China Hospital trials with current recruitment status updated daily.

Clinical Trials by West China Hospital

NCT07636798 Phase 1, Phase 2
Recruiting

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Biliary Tract Cancer
NCT06950827
Recruiting

Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT06242418 Phase 2
Recruiting

CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)

Colon Cancer
NCT07101679 Phase 2
Recruiting

A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT06345898 EARLY_Phase 1
Recruiting

Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)

X Linked Retinoschisis
NCT07567222 Phase 1
Recruiting

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Malignant Tumor
NCT07457281 Phase 1
Recruiting

GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study

Head and Neck Squamous Cell Carcinoma HNSCC
NCT07561723 Phase 1
Recruiting

IMP3-saRNA Vaccine in Advanced NSCLC

Non-Small Cell Lung Cancer
NCT06741982 Phase 1
Recruiting

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

HNSCC
NCT06586736
Recruiting

Physiological Studies in the Prone Position in Patients With ARDS

Acute Respiratory Distress Syndrome
NCT07799636
Recruiting

Early Warning and Stratified Diagnosis of Postoperative Respiratory Failure Based on Ventilator Waveform Image Features

Postoperative Respiratory Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology